Co-Diagnostics Inc [NASDAQ: CODX] slipped around -0.03 points on Thursday, while shares priced at $0.25 at the close of the session, down -10.58%.
Co-Diagnostics Inc stock is now -79.69% down from its year-to-date (YTD) trading value. CODX Stock saw the intraday high of $0.2543 and lowest of $0.2426 per share. The company’s 52-week high price is 2.23, which means current price is +10.73% above from all time high which was touched on 01/06/25.
Compared to the average trading volume of 402.59K shares, CODX reached a trading volume of 12106962 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Co-Diagnostics Inc [CODX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CODX shares is $5.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CODX stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Sidoti have made an estimate for Co-Diagnostics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 12, 2022. While these analysts kept the previous recommendation, Sidoti raised their target price to Buy. The new note on the price target was released on December 29, 2021, representing the official price target for Co-Diagnostics Inc stock.
The Price to Book ratio for the last quarter was 0.18, with the Price to Cash per share for the same quarter was set at 0.64.
How has CODX stock performed recently?
Co-Diagnostics Inc [CODX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -11.92. With this latest performance, CODX shares dropped by -15.50% in over the last four-week period, additionally sinking by -74.81% over the last 6 months – not to mention a drop of -66.41% in the past year of trading.
Co-Diagnostics Inc [CODX]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Co-Diagnostics Inc [CODX] shares currently have an operating margin of -7277.19% and a Gross Margin at -272.34%. Co-Diagnostics Inc’s Net Margin is presently recorded at -6318.09%.
Return on Equity for this stock declined to -50.57%, with Return on Assets sitting at -50.57%.
Earnings analysis for Co-Diagnostics Inc [CODX]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CODX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Co-Diagnostics Inc go to 37.69%.
Insider trade positions for Co-Diagnostics Inc [CODX]
There are presently around $17.44%, or 19.17% of CODX stock, in the hands of institutional investors. The top three institutional holders of CODX stocks are: VANGUARD GROUP INC with ownership of 1.78 million shares, which is approximately 5.913%. RENAISSANCE TECHNOLOGIES LLC, holding 0.59 million shares of the stock with an approximate value of $$0.73 million in CODX stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $$0.63 million in CODX stock with ownership which is approximately 1.6665%.
